Global Colorectal Cancer Screening Market 2022 by Company, Regions, Type and Application, Forecast to 2028

September 2022 | 100 pages | ID: GEDF5197B878EN
GlobalInfoResearch

Abstracts

The Colorectal Cancer Screening market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Colorectal Cancer Screening market size is estimated to be worth US$ 662.8 million in 2021 and is forecast to a readjusted size of USD 782.1 million by 2028 with a CAGR of 2.4% during review period. Hospitals accounting for % of the Colorectal Cancer Screening global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Stool-based Tests segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Colorectal Cancer Screening include Abbott, Clinical Genomics Technologies, Epigenomics Inc, Exact Sciences, and Roche, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Colorectal Cancer Screening market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

• Stool-based Tests
• Colonoscopy
• CT Colonography
• Others

Market segment by Application, can be divided into

• Hospitals
• Independent Diagnostic Labs
• Others

Market segment by players, this report covers

• Abbott
• Clinical Genomics Technologies
• Epigenomics Inc
• Exact Sciences
• Roche
• Hemosure Inc
• Novigenix SA
• Quidel
• Siemens
• Sysmex

Market segment by regions, regional analysis covers

• North America (United States, Canada, and Mexico)
• Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
• South America (Brazil, Argentina, Rest of South America)
• Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Colorectal Cancer Screening product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Colorectal Cancer Screening, with revenue, gross margin and global market share of Colorectal Cancer Screening from 2019 to 2022.

Chapter 3, the Colorectal Cancer Screening competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Colorectal Cancer Screening market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Colorectal Cancer Screening research findings and conclusion, appendix and data source.

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of Colorectal Cancer Screening
1.2 Classification of Colorectal Cancer Screening by Type
  1.2.1 Overview: Global Colorectal Cancer Screening Market Size by Type: 2017 Versus 2021 Versus 2028
  1.2.2 Global Colorectal Cancer Screening Revenue Market Share by Type in 2021
  1.2.3 Stool-based Tests
  1.2.4 Colonoscopy
  1.2.5 CT Colonography
  1.2.6 Others
1.3 Global Colorectal Cancer Screening Market by Application
  1.3.1 Overview: Global Colorectal Cancer Screening Market Size by Application: 2017 Versus 2021 Versus 2028
  1.3.2 Hospitals
  1.3.3 Independent Diagnostic Labs
  1.3.4 Others
1.4 Global Colorectal Cancer Screening Market Size & Forecast
1.5 Global Colorectal Cancer Screening Market Size and Forecast by Region
  1.5.1 Global Colorectal Cancer Screening Market Size by Region: 2017 VS 2021 VS 2028
  1.5.2 Global Colorectal Cancer Screening Market Size by Region, (2017-2022)
  1.5.3 North America Colorectal Cancer Screening Market Size and Prospect (2017-2028)
  1.5.4 Europe Colorectal Cancer Screening Market Size and Prospect (2017-2028)
  1.5.5 Asia-Pacific Colorectal Cancer Screening Market Size and Prospect (2017-2028)
  1.5.6 South America Colorectal Cancer Screening Market Size and Prospect (2017-2028)
  1.5.7 Middle East and Africa Colorectal Cancer Screening Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
  1.6.1 Colorectal Cancer Screening Market Drivers
  1.6.2 Colorectal Cancer Screening Market Restraints
  1.6.3 Colorectal Cancer Screening Trends Analysis

2 COMPANY PROFILES

2.1 Abbott
  2.1.1 Abbott Details
  2.1.2 Abbott Major Business
  2.1.3 Abbott Colorectal Cancer Screening Product and Solutions
  2.1.4 Abbott Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.1.5 Abbott Recent Developments and Future Plans
2.2 Clinical Genomics Technologies
  2.2.1 Clinical Genomics Technologies Details
  2.2.2 Clinical Genomics Technologies Major Business
  2.2.3 Clinical Genomics Technologies Colorectal Cancer Screening Product and Solutions
  2.2.4 Clinical Genomics Technologies Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.2.5 Clinical Genomics Technologies Recent Developments and Future Plans
2.3 Epigenomics Inc
  2.3.1 Epigenomics Inc Details
  2.3.2 Epigenomics Inc Major Business
  2.3.3 Epigenomics Inc Colorectal Cancer Screening Product and Solutions
  2.3.4 Epigenomics Inc Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.3.5 Epigenomics Inc Recent Developments and Future Plans
2.4 Exact Sciences
  2.4.1 Exact Sciences Details
  2.4.2 Exact Sciences Major Business
  2.4.3 Exact Sciences Colorectal Cancer Screening Product and Solutions
  2.4.4 Exact Sciences Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.4.5 Exact Sciences Recent Developments and Future Plans
2.5 Roche
  2.5.1 Roche Details
  2.5.2 Roche Major Business
  2.5.3 Roche Colorectal Cancer Screening Product and Solutions
  2.5.4 Roche Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.5.5 Roche Recent Developments and Future Plans
2.6 Hemosure Inc
  2.6.1 Hemosure Inc Details
  2.6.2 Hemosure Inc Major Business
  2.6.3 Hemosure Inc Colorectal Cancer Screening Product and Solutions
  2.6.4 Hemosure Inc Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.6.5 Hemosure Inc Recent Developments and Future Plans
2.7 Novigenix SA
  2.7.1 Novigenix SA Details
  2.7.2 Novigenix SA Major Business
  2.7.3 Novigenix SA Colorectal Cancer Screening Product and Solutions
  2.7.4 Novigenix SA Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.7.5 Novigenix SA Recent Developments and Future Plans
2.8 Quidel
  2.8.1 Quidel Details
  2.8.2 Quidel Major Business
  2.8.3 Quidel Colorectal Cancer Screening Product and Solutions
  2.8.4 Quidel Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.8.5 Quidel Recent Developments and Future Plans
2.9 Siemens
  2.9.1 Siemens Details
  2.9.2 Siemens Major Business
  2.9.3 Siemens Colorectal Cancer Screening Product and Solutions
  2.9.4 Siemens Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.9.5 Siemens Recent Developments and Future Plans
2.10 Sysmex
  2.10.1 Sysmex Details
  2.10.2 Sysmex Major Business
  2.10.3 Sysmex Colorectal Cancer Screening Product and Solutions
  2.10.4 Sysmex Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.10.5 Sysmex Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Colorectal Cancer Screening Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
  3.2.1 Top 3 Colorectal Cancer Screening Players Market Share in 2021
  3.2.2 Top 10 Colorectal Cancer Screening Players Market Share in 2021
  3.2.3 Market Competition Trend
3.3 Colorectal Cancer Screening Players Head Office, Products and Services Provided
3.4 Colorectal Cancer Screening Mergers & Acquisitions
3.5 Colorectal Cancer Screening New Entrants and Expansion Plans

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Colorectal Cancer Screening Revenue and Market Share by Type (2017-2022)
4.2 Global Colorectal Cancer Screening Market Forecast by Type (2023-2028)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Colorectal Cancer Screening Revenue Market Share by Application (2017-2022)
5.2 Global Colorectal Cancer Screening Market Forecast by Application (2023-2028)

6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

6.1 North America Colorectal Cancer Screening Revenue by Type (2017-2028)
6.2 North America Colorectal Cancer Screening Revenue by Application (2017-2028)
6.3 North America Colorectal Cancer Screening Market Size by Country
  6.3.1 North America Colorectal Cancer Screening Revenue by Country (2017-2028)
  6.3.2 United States Colorectal Cancer Screening Market Size and Forecast (2017-2028)
  6.3.3 Canada Colorectal Cancer Screening Market Size and Forecast (2017-2028)
  6.3.4 Mexico Colorectal Cancer Screening Market Size and Forecast (2017-2028)

7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION

7.1 Europe Colorectal Cancer Screening Revenue by Type (2017-2028)
7.2 Europe Colorectal Cancer Screening Revenue by Application (2017-2028)
7.3 Europe Colorectal Cancer Screening Market Size by Country
  7.3.1 Europe Colorectal Cancer Screening Revenue by Country (2017-2028)
  7.3.2 Germany Colorectal Cancer Screening Market Size and Forecast (2017-2028)
  7.3.3 France Colorectal Cancer Screening Market Size and Forecast (2017-2028)
  7.3.4 United Kingdom Colorectal Cancer Screening Market Size and Forecast (2017-2028)
  7.3.5 Russia Colorectal Cancer Screening Market Size and Forecast (2017-2028)
  7.3.6 Italy Colorectal Cancer Screening Market Size and Forecast (2017-2028)

8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION

8.1 Asia-Pacific Colorectal Cancer Screening Revenue by Type (2017-2028)
8.2 Asia-Pacific Colorectal Cancer Screening Revenue by Application (2017-2028)
8.3 Asia-Pacific Colorectal Cancer Screening Market Size by Region
  8.3.1 Asia-Pacific Colorectal Cancer Screening Revenue by Region (2017-2028)
  8.3.2 China Colorectal Cancer Screening Market Size and Forecast (2017-2028)
  8.3.3 Japan Colorectal Cancer Screening Market Size and Forecast (2017-2028)
  8.3.4 South Korea Colorectal Cancer Screening Market Size and Forecast (2017-2028)
  8.3.5 India Colorectal Cancer Screening Market Size and Forecast (2017-2028)
  8.3.6 Southeast Asia Colorectal Cancer Screening Market Size and Forecast (2017-2028)
  8.3.7 Australia Colorectal Cancer Screening Market Size and Forecast (2017-2028)

9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

9.1 South America Colorectal Cancer Screening Revenue by Type (2017-2028)
9.2 South America Colorectal Cancer Screening Revenue by Application (2017-2028)
9.3 South America Colorectal Cancer Screening Market Size by Country
  9.3.1 South America Colorectal Cancer Screening Revenue by Country (2017-2028)
  9.3.2 Brazil Colorectal Cancer Screening Market Size and Forecast (2017-2028)
  9.3.3 Argentina Colorectal Cancer Screening Market Size and Forecast (2017-2028)

10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION

10.1 Middle East & Africa Colorectal Cancer Screening Revenue by Type (2017-2028)
10.2 Middle East & Africa Colorectal Cancer Screening Revenue by Application (2017-2028)
10.3 Middle East & Africa Colorectal Cancer Screening Market Size by Country
  10.3.1 Middle East & Africa Colorectal Cancer Screening Revenue by Country (2017-2028)
  10.3.2 Turkey Colorectal Cancer Screening Market Size and Forecast (2017-2028)
  10.3.3 Saudi Arabia Colorectal Cancer Screening Market Size and Forecast (2017-2028)
  10.3.4 UAE Colorectal Cancer Screening Market Size and Forecast (2017-2028)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Colorectal Cancer Screening Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Colorectal Cancer Screening Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Colorectal Cancer Screening Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Colorectal Cancer Screening Revenue (USD Million) by Region (2017-2022)
Table 5. Global Colorectal Cancer Screening Revenue Market Share by Region (2023-2028)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Colorectal Cancer Screening Product and Solutions
Table 9. Abbott Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Clinical Genomics Technologies Corporate Information, Head Office, and Major Competitors
Table 11. Clinical Genomics Technologies Major Business
Table 12. Clinical Genomics Technologies Colorectal Cancer Screening Product and Solutions
Table 13. Clinical Genomics Technologies Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Epigenomics Inc Corporate Information, Head Office, and Major Competitors
Table 15. Epigenomics Inc Major Business
Table 16. Epigenomics Inc Colorectal Cancer Screening Product and Solutions
Table 17. Epigenomics Inc Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Exact Sciences Corporate Information, Head Office, and Major Competitors
Table 19. Exact Sciences Major Business
Table 20. Exact Sciences Colorectal Cancer Screening Product and Solutions
Table 21. Exact Sciences Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Roche Corporate Information, Head Office, and Major Competitors
Table 23. Roche Major Business
Table 24. Roche Colorectal Cancer Screening Product and Solutions
Table 25. Roche Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Hemosure Inc Corporate Information, Head Office, and Major Competitors
Table 27. Hemosure Inc Major Business
Table 28. Hemosure Inc Colorectal Cancer Screening Product and Solutions
Table 29. Hemosure Inc Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Novigenix SA Corporate Information, Head Office, and Major Competitors
Table 31. Novigenix SA Major Business
Table 32. Novigenix SA Colorectal Cancer Screening Product and Solutions
Table 33. Novigenix SA Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Quidel Corporate Information, Head Office, and Major Competitors
Table 35. Quidel Major Business
Table 36. Quidel Colorectal Cancer Screening Product and Solutions
Table 37. Quidel Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Siemens Corporate Information, Head Office, and Major Competitors
Table 39. Siemens Major Business
Table 40. Siemens Colorectal Cancer Screening Product and Solutions
Table 41. Siemens Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Sysmex Corporate Information, Head Office, and Major Competitors
Table 43. Sysmex Major Business
Table 44. Sysmex Colorectal Cancer Screening Product and Solutions
Table 45. Sysmex Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Colorectal Cancer Screening Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Colorectal Cancer Screening Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Colorectal Cancer Screening by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Colorectal Cancer Screening Players Head Office, Products and Services Provided
Table 50. Colorectal Cancer Screening Mergers & Acquisitions in the Past Five Years
Table 51. Colorectal Cancer Screening New Entrants and Expansion Plans
Table 52. Global Colorectal Cancer Screening Revenue (USD Million) by Type (2017-2022)
Table 53. Global Colorectal Cancer Screening Revenue Share by Type (2017-2022)
Table 54. Global Colorectal Cancer Screening Revenue Forecast by Type (2023-2028)
Table 55. Global Colorectal Cancer Screening Revenue by Application (2017-2022)
Table 56. Global Colorectal Cancer Screening Revenue Forecast by Application (2023-2028)
Table 57. North America Colorectal Cancer Screening Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Colorectal Cancer Screening Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Colorectal Cancer Screening Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Colorectal Cancer Screening Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Colorectal Cancer Screening Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Colorectal Cancer Screening Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Colorectal Cancer Screening Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Colorectal Cancer Screening Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Colorectal Cancer Screening Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Colorectal Cancer Screening Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Colorectal Cancer Screening Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Colorectal Cancer Screening Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Colorectal Cancer Screening Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Colorectal Cancer Screening Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Colorectal Cancer Screening Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Colorectal Cancer Screening Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Colorectal Cancer Screening Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Colorectal Cancer Screening Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Colorectal Cancer Screening Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Colorectal Cancer Screening Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Colorectal Cancer Screening Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Colorectal Cancer Screening Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Colorectal Cancer Screening Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Colorectal Cancer Screening Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Colorectal Cancer Screening Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Colorectal Cancer Screening Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Colorectal Cancer Screening Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Colorectal Cancer Screening Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Colorectal Cancer Screening Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Colorectal Cancer Screening Revenue by Country (2023-2028) & (USD Million)

List Of Figures

LIST OF FIGURES

Figure 1. Colorectal Cancer Screening Picture
Figure 2. Global Colorectal Cancer Screening Revenue Market Share by Type in 2021
Figure 3. Stool-based Tests
Figure 4. Colonoscopy
Figure 5. CT Colonography
Figure 6. Others
Figure 7. Colorectal Cancer Screening Revenue Market Share by Application in 2021
Figure 8. Hospitals Picture
Figure 9. Independent Diagnostic Labs Picture
Figure 10. Others Picture
Figure 11. Global Colorectal Cancer Screening Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Colorectal Cancer Screening Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Colorectal Cancer Screening Revenue Market Share by Region (2017-2028)
Figure 14. Global Colorectal Cancer Screening Revenue Market Share by Region in 2021
Figure 15. North America Colorectal Cancer Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Colorectal Cancer Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Colorectal Cancer Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Colorectal Cancer Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Colorectal Cancer Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Colorectal Cancer Screening Market Drivers
Figure 21. Colorectal Cancer Screening Market Restraints
Figure 22. Colorectal Cancer Screening Market Trends
Figure 23. Abbott Recent Developments and Future Plans
Figure 24. Clinical Genomics Technologies Recent Developments and Future Plans
Figure 25. Epigenomics Inc Recent Developments and Future Plans
Figure 26. Exact Sciences Recent Developments and Future Plans
Figure 27. Roche Recent Developments and Future Plans
Figure 28. Hemosure Inc Recent Developments and Future Plans
Figure 29. Novigenix SA Recent Developments and Future Plans
Figure 30. Quidel Recent Developments and Future Plans
Figure 31. Siemens Recent Developments and Future Plans
Figure 32. Sysmex Recent Developments and Future Plans
Figure 33. Global Colorectal Cancer Screening Revenue Share by Players in 2021
Figure 34. Colorectal Cancer Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 35. Global Top 3 Players Colorectal Cancer Screening Revenue Market Share in 2021
Figure 36. Global Top 10 Players Colorectal Cancer Screening Revenue Market Share in 2021
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 38. Global Colorectal Cancer Screening Revenue Share by Type in 2021
Figure 39. Global Colorectal Cancer Screening Market Share Forecast by Type (2023-2028)
Figure 40. Global Colorectal Cancer Screening Revenue Share by Application in 2021
Figure 41. Global Colorectal Cancer Screening Market Share Forecast by Application (2023-2028)
Figure 42. North America Colorectal Cancer Screening Sales Market Share by Type (2017-2028)
Figure 43. North America Colorectal Cancer Screening Sales Market Share by Application (2017-2028)
Figure 44. North America Colorectal Cancer Screening Revenue Market Share by Country (2017-2028)
Figure 45. United States Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Colorectal Cancer Screening Sales Market Share by Type (2017-2028)
Figure 49. Europe Colorectal Cancer Screening Sales Market Share by Application (2017-2028)
Figure 50. Europe Colorectal Cancer Screening Revenue Market Share by Country (2017-2028)
Figure 51. Germany Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Colorectal Cancer Screening Sales Market Share by Type (2017-2028)
Figure 57. Asia-Pacific Colorectal Cancer Screening Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Colorectal Cancer Screening Revenue Market Share by Region (2017-2028)
Figure 59. China Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South Korea Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Colorectal Cancer Screening Sales Market Share by Type (2017-2028)
Figure 66. South America Colorectal Cancer Screening Sales Market Share by Application (2017-2028)
Figure 67. South America Colorectal Cancer Screening Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East and Africa Colorectal Cancer Screening Sales Market Share by Type (2017-2028)
Figure 71. Middle East and Africa Colorectal Cancer Screening Sales Market Share by Application (2017-2028)
Figure 72. Middle East and Africa Colorectal Cancer Screening Revenue Market Share by Country (2017-2028)
Figure 73. Turkey Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. UAE Colorectal Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source